One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
JAMA Dermatology.
doi : 10.1001/jamadermatol.2023.4000
Volume 160(9) pgs. 911-1015 September 2024
Extending Maintenance Dosing Intervals for Guselkumab in the Treatment of Patients With Psoriasis.
Advancing Research in Cutaneous Squamous Cell Carcinoma-Precision Management Requires Precision Data.
Does the Germline Genome Encode for the Invasiveness of a Cutaneous Melanoma?.
Multinational Drug Survival Study of Omalizumab in Patients With Chronic Urticaria and Potential Predictors for Discontinuation.
Systemic Immunomodulatory Treatments for Atopic Dermatitis: Living Systematic Review and Network Meta-Analysis Update.
Immune-Mediated and Psychiatric Comorbidities Among Patients Newly Diagnosed With Alopecia Areata.
Noninferiority of 16-Week vs 8-Week Guselkumab Dosing in Super Responders for Maintaining Control of Psoriasis: The GUIDE Randomized Clinical Trial.
Exploring the Germline Genetics of In Situ and Invasive Cutaneous Melanoma: A Genome-Wide Association Study Meta-Analysis.
Sexual Orientation and Lifetime Prevalence of Skin Cancer Across Racial and Ethnic Groups.
Area Deprivation and Disease Severity in Adult Patients With Discoid Lupus Erythematosus.
Standardizing Retrospective Observational Research in Cutaneous Squamous Cell Carcinoma: Expert Panel Guidelines from ITSCC.
Exanthematous Eruption in a Patient With Known Chronic Graft-vs-Host Disease and Recent Measles Vaccination.
Frequency of Skin Biopsies for Psoriasis by Race and Ethnicity.
Favorable Response to Type 2 Inhibitors in Patients With Darier Disease.
Rapid Improvement in Refractory Acute Generalized Exanthematous Pustulosis With Spesolimab.
